MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
667
Unique beneficiaries
—
Total services
7,283
Distinct HCPCS
7
Medicare payment
$184K
PRESCRIBING · PART D · 2024
Total Rx claims
2,054
Beneficiaries
—
Total drug cost
$1.1M
Distinct drugs
26
Brand share
54.1%
Top prescribed drugs
Glipizide264 claims
Levothyroxine Sodium227 claims
Semaglutide205 claims
Dulaglutide187 claims
Metformin Hcl108 claims
QUALITY · MIPS · 2024
Final MIPS score
84.9
Quality
75.9
Cost
74.6
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.42%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
CROSS-REFERENCE